Variant report
Variant | esv2762605 |
---|---|
Chromosome Location | chr6:87488081-87495504 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:87494778..87497258-chr6:87499826..87502214,2 | K562 | blood: | |
2 | chr6:87433571..87436009-chr6:87486240..87488175,2 | MCF-7 | breast: | |
3 | chr6:87494199..87497258-chr6:87499220..87502214,3 | K562 | blood: | |
4 | chr6:87432080..87434373-chr6:87487910..87490262,2 | MCF-7 | breast: | |
5 | chr6:87491790..87492456-chr6:87566446..87567164,4 | MCF-7 | breast: | |
6 | chr6:87433212..87433993-chr6:87487281..87488109,4 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558449690 | chr6:87493831-87493832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs573459582 | chr6:87493834-87493835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540966109 | chr6:87494136-87494137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561516956 | chr6:87494139-87494140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573614805 | chr6:87494161-87494162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114843012 | chr6:87494319-87494320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs78679991 | chr6:87494361-87494362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189367088 | chr6:87494378-87494379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376471964 | chr6:87494408-87494409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533035773 | chr6:87494517-87494518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139872045 | chr6:87494525-87494526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551164240 | chr6:87494528-87494529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559963973 | chr6:87494529-87494530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527583996 | chr6:87494561-87494562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs549294912 | chr6:87494663-87494664 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9351108 | chr6:87494690-87494691 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
17 | rs148352963 | chr6:87494691-87494692 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551058120 | chr6:87494760-87494761 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181415695 | chr6:87494827-87494828 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs117956394 | chr6:87494837-87494838 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112781791 | chr6:87494889-87494890 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs147068244 | chr6:87494912-87494913 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534209948 | chr6:87495066-87495067 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs367606376 | chr6:87495082-87495083 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186361796 | chr6:87495093-87495094 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138361906 | chr6:87495109-87495110 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529060441 | chr6:87495120-87495121 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543815640 | chr6:87495124-87495125 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562197229 | chr6:87495126-87495127 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548670251 | chr6:87495359-87495360 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369772089 | chr6:87495360-87495361 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570919890 | chr6:87495370-87495371 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374522879 | chr6:87495371-87495372 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375145332 | chr6:87495388-87495389 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs527511315 | chr6:87495444-87495445 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs190582692 | chr6:87495477-87495478 | Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abnormal development | 18461090 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 19490664 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:87493800-87494600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr6:87493800-87494800 | Enhancers | Fetal Kidney | kidney |
3 | chr6:87494600-87494800 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr6:87494600-87494800 | Enhancers | Fetal Intestine Large | intestine |
5 | chr6:87494800-87495400 | Weak transcription | Fetal Intestine Large | intestine |
6 | chr6:87494800-87495600 | Weak transcription | Fetal Kidney | kidney |
7 | chr6:87494800-87495800 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr6:87495400-87496200 | Enhancers | Fetal Intestine Large | intestine |